SEC Form 4 · accession 0001144204-16-136409
Neurotrope, Inc. · NTRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susanne Wilke
Officer — Chief Executive Officer · Director
Period of report
Nov 21, 2016
Accepted (ET)
Nov 23, 2016 · 5:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001513856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF2,F1 | $0.33 | Nov 21, 2016 | A | 1,739,835 | A | — | Nov 21, 2026 | Common Stock | 1,739,835 | 1,739,835 | D |
Explanation of responses
- F1One half of the stock options vest immediately upon grant and the remaining one half vest in equal daily installments over a four-year period beginning on the date of grant.
- F2These options were granted in connection with the Issuer's grant to certain officers, directors and employees following the final closing of a private placement on November 21, 2016.